Human FcgRIIBC PharmaGenie ELISA Kit (SBRS0560)

Quantitative measurement of the FcgRIIB-C receptor in human samples is supported by this Assay Genie ELISA kit, developed for immunology and antibody therapeutics research. FcgRIIB-C is a low-affinity IgG Fc receptor variant implicated in B-cell signaling and immune complex regulation, making it a relevant biomarker target in autoimmune disease studies, vaccine response investigations, and monoclonal antibody drug development programs.

The kit is supplied in a microplate configuration with all reagents required to run the assay, including pre-coated plates, detection antibodies, and calibration standards. It accommodates cell culture supernatant, plasma, and serum specimens, providing flexibility across in vitro experimental models and translational research workflows. Detection relies on an enzymatic reaction producing a measurable optical signal, enabling straightforward quantification using a standard plate reader configured for absorbance measurements.

Each kit provides materials sufficient for 96 individual determinations, supporting both targeted single-sample evaluation and higher-throughput screening in pharmaceutical and academic research settings. Investigators studying Fc receptor biology, antibody-dependent cellular responses, or immunomodulatory therapeutics can apply this kit to monitor FcgRIIB-C expression levels across experimental conditions, including dose-response studies and time-course analyses.

The product belongs to Assay Genie's PharmaGenie product family, a collection of immunoassays targeting biomarkers relevant to drug discovery and translational immunology research.